Bio Medica Laboratories Peer Comparison

NSE: BMLL

₹149.90

₹1.90 (1.28%)

As on 11-Nov-2026IST

Market cap

₹189 Cr

Revenue (TTM)

₹43 Cr

P/E Ratio

16

P/B Ratio

6.3

Div. Yield

0 %

Edit

	Bio Medica Laboratories	Entero Health	VijayPD Ceutical	Speciality Medicines	Goldline Pharmaceutical
Market cap (₹ Cr)	189	8,733	136	141	29
Revenue (₹ Cr)	43	7,644	100	75	31
Net Profit (₹ Cr)	11.89	191.80	5.00	13.03	4.12
Net Margin (%)	27.57	2.50	4.79	17.12	13.20
RoE (%)	57.64	8.35	9.53	25.60	39.41
Price to Earnings	16.00	62.67	27.24	10.85	7.11
Price-To-Book	6.30	4.91	2.60	1.99	1.22

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Bio Medica Laboratories	Entero Health	VijayPD Ceutical	Speciality Medicines	Goldline Pharmaceutical
Operating Revenue	43.09	6,591.21	100.23	75.29	31.20
Total Income	43.11	6,610.45	104.35	76.11	31.20
Total Expenditure	23.11	6,325.26	95.56	61.60	24.12
EBITDA	19.98	265.96	4.67	13.68	7.08
Depreciation	1.16	43.29	0.65	0.17	0.24
EBIT	18.81	222.66	4.02	13.51	6.84
Interest	2.58	54.39	1.66	1.32	1.46
Other Income	0.02	19.24	4.12	0.83	0.00
Exceptional Items	--	-8.18	-0.01	--	--
Profit before Tax	16.25	179.34	6.47	13.02	5.39
Provision for Tax	4.37	33.50	1.47	-0.01	1.27
Profit after Tax	11.89	145.84	5.00	13.03	4.12

Liabilities (₹ Cr)

	Bio Medica Laboratories	Entero Health	VijayPD Ceutical	Speciality Medicines	Goldline Pharmaceutical
Shareholder's Funds	26.51	1,688.61	52.48	71.19	14.25
Minority Interest	-6.17	63.94	-0.08	--	--
Non-Current Liabilities	33.45	206.12	4.66	5.15	2.43
Current Liabilities	19.18	1,587.57	42.23	18.88	12.11
Total Liabilities	73.31	3,600.22	99.64	95.22	28.87

Assets (₹ Cr)

	Bio Medica Laboratories	Entero Health	VijayPD Ceutical	Speciality Medicines	Goldline Pharmaceutical
Non-Current Assets	18.31	1,037.80	23.77	6.26	2.75
Current Assets	54.67	2,503.13	75.53	88.97	26.05
Total Assets	73.31	3,600.22	99.64	95.22	28.87
Total Debt*	39.99	566.68	36.71	6.64	9.16
Net Current Assets	35.48	915.56	33.30	70.09	13.93
Contingent Liabilities	--	5.51	0.14	--	3.37

Cashflow (₹ Cr)

	Bio Medica Laboratories	Entero Health	VijayPD Ceutical	Speciality Medicines	Goldline Pharmaceutical
Cash From Operating Activities	-6.03	96.20	-8.61	-1.28	2.81
Cash Flow from Investing Activities	-2.31	-303.06	-13.33	-2.83	-0.06
Cash from Financing Activities	8.43	123.66	31.59	27.82	-3.40
Net Cash Inflow / Outflow	0.09	-83.20	9.65	23.70	-0.65

Ratios

Profitability Ratios

	Bio Medica Laboratories	Entero Health	VijayPD Ceutical	Speciality Medicines	Goldline Pharmaceutical
ROCE (%)	39.14	10.93	9.12	25.26	30.60
ROE (%)	57.64	8.57	9.53	25.60	39.41
ROA (%)	21.33	4.68	5.04	19.27	14.98
EBIT Margin (%)	46.41	4.33	8.77	19.27	22.70
Net Margin (%)	27.57	2.21	4.79	17.12	13.20
Cash Profit Margin (%)	30.29	2.87	5.64	17.54	13.97

Growth Ratios

	Bio Medica Laboratories	Entero Health	VijayPD Ceutical	Speciality Medicines	Goldline Pharmaceutical
Revenue Growth (%)	12.45	29.35	0.00	29.20	11.20
EBIT Growth (%)	29.01	35.13	--	54.39	16.95
Net Profit Growth (%)	22.50	35.75	0.00	81.11	45.26
EPS Growth (%)	21.40	21.32	0.00	32.67	45.26
Book Value Growth (%)	79.96	-2.19	0.00	132.49	47.19

Valuation Ratios

	Bio Medica Laboratories	Entero Health	VijayPD Ceutical	Speciality Medicines	Goldline Pharmaceutical
Price / Earnings	0.00	47.12	25.46	8.49	0.00
Price / Book Value	0.00	3.22	2.43	1.55	0.00
Dividend Yield (%)	--	0.00	0.00	0.00	--
EV/EBITDA	2.45	20.43	16.66	6.39	2.44
Market Cap (₹ Cr)	0.00	5,420.61	127.33	110.62	0.00

Solvency Ratios

	Bio Medica Laboratories	Entero Health	VijayPD Ceutical	Speciality Medicines	Goldline Pharmaceutical
Debt to Equity	1.51	0.34	0.70	0.09	0.64
Short term debt to equity ratio	0.22	0.26	0.48	0.01	0.42
Current Ratio	2.85	1.58	1.79	4.71	2.15
Quick Ratio	0.95	1.05	1.49	3.21	1.64
Interest Coverage	7.29	4.30	4.89	10.87	4.70

Operating Efficiency Ratios

	Bio Medica Laboratories	Entero Health	VijayPD Ceutical	Speciality Medicines	Goldline Pharmaceutical
Debtors to sales (%)	25.19	18.39	30.52	35.20	51.70
Asset Turnover	0.77	2.11	1.01	1.11	1.13
Receivable days	63.33	56.56	111.39	87.52	156.90
Inventory Days	230.85	41.57	45.39	110.76	75.99
Payable days	181.09	34.66	32.72	43.45	64.86
Cash Conversion Cycle	113.10	63.47	124.06	154.84	168.03